Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENDI Corp.ENDI · Entity 9562 | Chief Financial Officer | February 28, 2023 | March 02, 2023 |
| ENTERPRISE DIVERSIFIED, INC.SYTE · Entity 143010 | Director · Chief Financial Officer | February 03, 2021 | February 05, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENDI Corp.
Report date February 28, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 45,348 |
Reported balance
After 2023-02-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-02-28 · Grant · Acquired 45,348 · Balance 45,348 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest in four equal annual installments with the first installment vesting on January 1, 2025, subject to receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest in four equal annual installments with the first installment vesting on January 1, 2025, subject to receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year.
ENTERPRISE DIVERSIFIED, INC.
Report date February 03, 2021 · Filed February 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,529 |
Reported balance
After 2021-02-03 transaction · row 1
1 source rowRow 1 · 2021-02-03 · Grant · Acquired 5,643 · Balance 8,529 F1: No price was paid, as the shares were acquired by virtue of the Issuer determining to issue shares of Common Stock in lieu of cash payment of $30,000 in 2020 Board of Directors fees payable to Ms. Kleinhammer. The number of shares that were issued was determined by the Issuer based on the Bloomberg Prior 90 Day Volume Weighted Average Price (VWAP) as of January 31, 2021, which equaled $5.3166 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: No price was paid, as the shares were acquired by virtue of the Issuer determining to issue shares of Common Stock in lieu of cash payment of $30,000 in 2020 Board of Directors fees payable to Ms. Kleinhammer. The number of shares that were issued was determined by the Issuer based on the Bloomberg Prior 90 Day Volume Weighted Average Price (VWAP) as of January 31, 2021, which equaled $5.3166 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 2, 2023 16:49 UTC | ENDI Corp. ENDI · Entity 9562 | GrantRestricted Stock Units · Derivative | 45,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-005239 · rdgdoc.xml · derivative · entry 1 Kleinhammer Alea Ann · CIK 0001755814 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,348 Underlying: Class A Common Stock · 45,348 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest in four equal annual installments with the first installment vesting on January 1, 2025, subject to receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year. F2 · derivative.exercise_date: The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest in four equal annual installments with the first installment vesting on January 1, 2025, subject to receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year. F2 · derivative.expiration_date: The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest in four equal annual installments with the first installment vesting on January 1, 2025, subject to receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year. F2 · derivative.underlying_shares: The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest in four equal annual installments with the first installment vesting on January 1, 2025, subject to receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year. F2 · balance_after: The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest in four equal annual installments with the first installment vesting on January 1, 2025, subject to receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 21:47 UTC | ENDI Corp. ENDI · Entity 9562 | PurchaseClass A Common Stock | 1,500 | $5.37 | $8,053.50 |
DisclosureSEC source: 0000919574-22-005217 · ownership.xml · nonDerivative · entry 1 Kleinhammer Alea Ann · CIK 0001755814 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,029 Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 13:12 UTC | ENTERPRISE DIVERSIFIED, INC. SYTE · Entity 143010 | GrantCommon Stock | 5,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001755814-21-000001 · primary_doc.xml · nonDerivative · entry 1 Kleinhammer Alea Ann · CIK 0001755814 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,529 F1 · price: No price was paid, as the shares were acquired by virtue of the Issuer determining to issue shares of Common Stock in lieu of cash payment of $30,000 in 2020 Board of Directors fees payable to Ms. Kleinhammer. The number of shares that were issued was determined by the Issuer based on the Bloomberg Prior 90 Day Volume Weighted Average Price (VWAP) as of January 31, 2021, which equaled $5.3166 per share. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 16:30 UTC | ENTERPRISE DIVERSIFIED, INC. SYTE · Entity 143010 | GrantCommon Stock | 2,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001755814-20-000001 · primary_doc.xml · nonDerivative · entry 1 Kleinhammer Alea Ann · CIK 0001755814 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,886 F1 · price: No price was paid, as the shares were acquired by virtue of the Issuer determining to issue shares of Common Stock in lieu of cash payment of $10,000 in 2019 Board of Directors fees payable to Ms. Kleinhammer. The number of shares that were issued was determined by the Issuer based on the Bloomberg Prior 90 Day Volume Weighted Average Price (VWAP) as of January 31, 2020, which equaled $3.6537 per share. Read SEC document |
| May 15, 2019 Filed May 15, 2019 18:57 UTC | ENTERPRISE DIVERSIFIED, INC. SYTE · Entity 143010 | PurchaseCommon Stock | 150 | $6.50 | $975.00 |
DisclosureSEC source: 0001755814-19-000001 · primary_doc.xml · nonDerivative · entry 1 Kleinhammer Alea Ann · CIK 0001755814 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.